$178 Million is the total value of Caligan Partners LP's 13 reported holdings in Q2 2023. The portfolio turnover from Q1 2023 to Q2 2023 was 50.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ANIK | Buy | ANIKA THERAPEUTICS INC | $18,713,160 | -8.9% | 720,291 | +0.7% | 10.52% | -26.5% |
| EXEL | Buy | EXELIXIS INC | $17,404,050 | +5.5% | 910,730 | +7.1% | 9.79% | -14.9% |
| ICPT | New | INTERCEPT PHARMACEUTICALS INC | $14,306,221 | – | 1,293,510 | +100.0% | 8.05% | – |
| New | INTERCEPT PHARMACEUTICALS INCput | $13,272,000 | – | 1,200,000 | +100.0% | 7.46% | – | |
| EOLS | Buy | EVOLUS INC | $12,796,189 | -0.7% | 1,760,136 | +15.5% | 7.20% | -20.0% |
| AGIO | Buy | AGIOS PHARMACEUTICALS INC | $136,871 | +37.5% | 4,833 | +11.5% | 0.08% | +11.6% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-08-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| LIQUIDIA CORP | 4 | Q3 2023 | 49.0% |
| ANIKA THERAPEUTICS INC | 4 | Q3 2023 | 14.6% |
| STANDARD BIOTOOLS INC | 4 | Q3 2023 | 11.7% |
| EVOLUS INC | 4 | Q3 2023 | 10.9% |
| ALIMERA SCIENCES INC | 4 | Q3 2023 | 24.0% |
| ADMA BIOLOGICS INC | 4 | Q3 2023 | 8.6% |
| VERONA PHARMA PLC | 4 | Q3 2023 | 4.0% |
| SOCIETAL CDMO INC | 4 | Q3 2023 | 2.0% |
| AGIOS PHARMACEUTICALS INC | 4 | Q3 2023 | 0.1% |
| EXELIXIS INC | 3 | Q3 2023 | 11.5% |
View Caligan Partners LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| ALIMERA SCIENCES INC | August 03, 2023 | 17,635,154 | 33.1% |
| EXELIXIS, INC. | June 02, 2023 | 910,730 | 0.3% |
| ADMA BIOLOGICS, INC. | December 09, 2022 | 10,264,311 | 4.6% |
| AMAG PHARMACEUTICALS, INC. | November 16, 2020 | ? | ? |
| Knowles Corp | September 30, 2019 | 102,674 | 0.0% |
View Caligan Partners LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-13 |
| SC 13D/A | 2024-03-06 |
| 4 | 2024-02-22 |
| 13F-HR | 2024-02-14 |
| SC 13D/A | 2024-01-08 |
| 4 | 2023-12-14 |
| SC 13D/A | 2023-12-14 |
| 4 | 2023-11-29 |
| 13F-HR | 2023-11-14 |
| 4 | 2023-09-15 |
View Caligan Partners LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.